{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T23:02:40Z","timestamp":1781478160762,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["75F40120C00123"],"award-info":[{"award-number":["75F40120C00123"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s40264-023-01276-6","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T09:03:10Z","timestamp":1677229390000},"page":"309-318","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Use of Structured Electronic Health Records Data Elements for the Development of Computable Phenotypes to Identify Potential Adverse Events Associated with Intravenous Immunoglobulin Infusion"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5079-9920","authenticated-orcid":false,"given":"Jillian H.","family":"Hurst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Brucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congwen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Driscoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley P.","family":"Hostetler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bari","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc D.","family":"Samsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan E.","family":"Reller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Strouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy Ke","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gra\u00e7a M.","family":"Dores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Lee","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin A.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,24]]},"reference":[{"key":"1276_CR1","unstructured":"United States Food and Drug Adminitration. What is a Serious Adverse Event? [Internet]. 2022. https:\/\/www.fda.gov\/safety\/reporting-serious-problems-fda\/what-serious-adverse-event. Accessed 10 Jan 2022."},{"key":"1276_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s40264-013-0018-x","volume":"36","author":"PM Coloma","year":"2013","unstructured":"Coloma PM, Trifir\u00f2 G, Patadia V, Sturkenboom M. Postmarketing safety surveillance: where does signal detection using electronic healthcare records fit into the big picture? Drug Saf. 2013;36:183\u201397.","journal-title":"Drug Saf"},{"key":"1276_CR3","doi-asserted-by":"publisher","first-page":"e226","DOI":"10.1136\/amiajnl-2013-001926","volume":"20","author":"RL Richesson","year":"2013","unstructured":"Richesson RL, Hammond WE, Nahm M, Wixted D, Simon GE, Robinson JG, et al. Electronic health records based phenotyping in next-generation clinical trials: a perspective from the NIH Health Care Systems Collaboratory. J Am Med Inform Assoc. 2013;20:e226\u201331.","journal-title":"J Am Med Inform Assoc"},{"key":"1276_CR4","doi-asserted-by":"publisher","DOI":"10.1017\/cts.2020.499","volume":"5","author":"JH Hurst","year":"2020","unstructured":"Hurst JH, Liu Y, Maxson PJ, Permar SR, Boulware LE, Goldstein BA. Development of an electronic health records datamart to support clinical and population health research. J Clin Transl Sci. 2020;5: e13.","journal-title":"J Clin Transl Sci."},{"key":"1276_CR5","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.anai.2020.07.009","volume":"125","author":"M Tang","year":"2020","unstructured":"Tang M, Goldstein BA, He J, Hurst JH, Lang JE. Performance of a computable phenotype for pediatric asthma using the problem list. Ann Allergy Asthma Immunol. 2020;125:611-613.e1.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1276_CR6","volume":"39","author":"J Graham","year":"2022","unstructured":"Graham J, Iverson A, Monteiro J, Weiner K, Southall K, Schiller K, et al. Applying computable phenotypes within a common data model to identify heart failure patients for an implantable cardiac device registry. Int J Cardiol Heart Vasc. 2022;39: 100974.","journal-title":"Int J Cardiol Heart Vasc."},{"key":"1276_CR7","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi J-C, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130\u20139.","journal-title":"Med Care"},{"key":"1276_CR8","first-page":"4","volume":"7","author":"J Weeks","year":"2019","unstructured":"Weeks J, Pardee R. Learning to share health care data: a brief timeline of influential common data models and distributed health data networks in U.S. Health Care Research. EGEMS (Wash DC). 2019;7:4.","journal-title":"EGEMS (Wash DC)."},{"key":"1276_CR9","doi-asserted-by":"publisher","first-page":"426","DOI":"10.2500\/aap.2016.37.3987","volume":"37","author":"FA Bonilla","year":"2016","unstructured":"Bonilla FA. Intravenous and subcutaneous immunoglobulin G replacement therapy. Allergy Asthma Proc. 2016;37:426\u201331.","journal-title":"Allergy Asthma Proc"},{"key":"1276_CR10","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jaci.2016.09.023","volume":"139","author":"EE Perez","year":"2017","unstructured":"Perez EE, Orange JS, Bonilla F, Chinen J, Chinn IK, Dorsey M, et al. Update on the use of immunoglobulin in human disease: a review of evidence. J Allergy Clin Immunol. 2017;139:S1-46.","journal-title":"J Allergy Clin Immunol"},{"key":"1276_CR11","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3389\/fimmu.2018.01299","volume":"9","author":"Y Guo","year":"2018","unstructured":"Guo Y, Tian X, Wang X, Xiao Z. adverse effects of immunoglobulin therapy. Front Immunol. 2018;9:1299.","journal-title":"Front Immunol"},{"key":"1276_CR12","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/ajh.24358","volume":"91","author":"EM Ammann","year":"2016","unstructured":"Ammann EM, Haskins CB, Fillman KM, Ritter RL, Gu X, Winiecki SK, et al. Intravenous immune globulin and thromboembolic adverse events: a systematic review and meta-analysis of RCTs. Am J Hematol. 2016;91:594\u2013605.","journal-title":"Am J Hematol"},{"key":"1276_CR13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.autrev.2015.09.002","volume":"15","author":"P Cherin","year":"2016","unstructured":"Cherin P, Marie I, Michallet M, Pelus E, Dantal J, Crave J-C, et al. Management of adverse events in the treatment of patients with immunoglobulin therapy: a review of evidence. Autoimmun Rev. 2016;15:71\u201381.","journal-title":"Autoimmun Rev"},{"key":"1276_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fimmu.2015.00011","volume":"6","author":"PJ Sp\u00e4th","year":"2015","unstructured":"Sp\u00e4th PJ, Granata G, La Marra F, Kuijpers TW, Quinti I. On the dark side of therapies with immunoglobulin concentrates: the adverse events. Front Immunol. 2015;6:11.","journal-title":"Front Immunol"},{"key":"1276_CR15","unstructured":"R Core Team. R: A language and environment for statistical computing. [Internet]. R Foundation for Statistical Computing. http:\/\/www.R-project.org\/. Accessed 10 Jan 2022."},{"key":"1276_CR16","doi-asserted-by":"publisher","unstructured":"Di Giovanni R, Cochrane A, Parker J, Lewis DJ. Adverse events in the digital age and where to find them. Pharmacoepidemiol Drug Saf. 2022;31(11):1131\u20131139. https:\/\/doi.org\/10.1002\/pds.5532","DOI":"10.1002\/pds.5532"},{"key":"1276_CR17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/ene.12287","volume":"21","author":"LH Markvardsen","year":"2014","unstructured":"Markvardsen LH, Christiansen I, Harbo T, Jakobsen J. Hemolytic anemia following high dose intravenous immunoglobulin in patients with chronic neurological disorders. Eur J Neurol. 2014;21:147\u201352.","journal-title":"Eur J Neurol"},{"key":"1276_CR18","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12911-021-01520-y","volume":"21","author":"H Shin","year":"2021","unstructured":"Shin H, Lee S. An OMOP-CDM based pharmacovigilance data-processing pipeline (PDP) providing active surveillance for ADR signal detection from real-world data sources. BMC Med Inform Decis Mak. 2021;21:159.","journal-title":"BMC Med Inform Decis Mak"},{"key":"1276_CR19","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/cei.13665","volume":"206","author":"C Martinez","year":"2021","unstructured":"Martinez C, Wallenhorst C, van Nunen S. Intravenous immunoglobulin and the current risk of moderate and severe anaphylactic events, a cohort study. Clin Exp Immunol. 2021;206:384\u201394.","journal-title":"Clin Exp Immunol"},{"key":"1276_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.intimp.2016.12.030","volume":"44","author":"G Spadaro","year":"2017","unstructured":"Spadaro G, Vultaggio A, Alberto Bosi A, Reichert D, Janssen J, Lamacchia D, et al. Rapid infusions of human normal immunoglobulin 50g\/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia. Int Immunopharmacol. 2017;44:38\u201342.","journal-title":"Int Immunopharmacol"},{"key":"1276_CR21","doi-asserted-by":"publisher","first-page":"e640","DOI":"10.1016\/S2352-3026(20)30227-1","volume":"7","author":"DM Arnold","year":"2020","unstructured":"Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, et al. Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial. Lancet Haematol. 2020;7:e640\u20138.","journal-title":"Lancet Haematol."},{"key":"1276_CR22","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/00043426-199705000-00015","volume":"19","author":"S Sava\u015fan","year":"1997","unstructured":"Sava\u015fan S, Tuzcu V, Warrier I, Karpawich P. Cardiac rhythm abnormalities during intravenous immunoglobulin G infusion for treatment of thrombocytopenia. J Pediatr Hematol Oncol. 1997;19:254\u20137.","journal-title":"J Pediatr Hematol Oncol"},{"key":"1276_CR23","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/mus.26884","volume":"62","author":"PH Jin","year":"2020","unstructured":"Jin PH, Shin SC, Dhamoon MS. Risk of thrombotic events after inpatient intravenous immunoglobulin or plasma exchange for neurologic disease: A case-crossover study. Muscle Nerve. 2020;62:327\u201332.","journal-title":"Muscle Nerve"},{"key":"1276_CR24","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000073059","volume":"50","author":"M Wittstock","year":"2003","unstructured":"Wittstock M, Benecke R, Zettl UK. Therapy with intravenous immunoglobulins: complications and side-effects. Eur Neurol. 2003;50:172\u20135.","journal-title":"Eur Neurol"},{"key":"1276_CR25","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009960","volume":"97","author":"EM Ammann","year":"2018","unstructured":"Ammann EM, Cuker A, Carnahan RM, Perepu US, Winiecki SK, Schweizer ML, et al. Chart validation of inpatient International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) administrative diagnosis codes for venous thromboembolism (VTE) among intravenous immune globulin (IGIV) users in the Sentinel Distributed Database. Medicine (Baltimore). 2018;97: e9960.","journal-title":"Medicine (Baltimore)"},{"key":"1276_CR26","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1182\/bloodadvances.2020002253","volume":"4","author":"CW Bruggeman","year":"2020","unstructured":"Bruggeman CW, Nagelkerke SQ, Lau W, Manlhiot C, de Haas M, van Bruggen R, et al. Treatment-associated hemolysis in Kawasaki disease: association with blood-group antibody titers in IVIG products. Blood Adv. 2020;4:3416\u201326.","journal-title":"Blood Adv"},{"key":"1276_CR27","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1111\/trf.13148","volume":"55","author":"DE Scott","year":"2015","unstructured":"Scott DE, Epstein JS. Hemolytic adverse events with immune globulin products: product factors and patient risks. Transfusion. 2015;55:S2-5.","journal-title":"Transfusion"},{"key":"1276_CR28","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1093\/jamia\/ocv202","volume":"23","author":"JC Kirby","year":"2016","unstructured":"Kirby JC, Speltz P, Rasmussen LV, Basford M, Gottesman O, Peissig PL, et al. PheKB: a catalog and workflow for creating electronic phenotype algorithms for transportability. J Am Med Inform Assoc. 2016;23:1046\u201352.","journal-title":"J Am Med Inform Assoc"},{"key":"1276_CR29","unstructured":"PCORnet: The National Patient-Centered Clinical Research Network [Internet]. [cited 2018 Oct 27]. https:\/\/pcornet.org\/. Accessed 10 Jan 2022."},{"key":"1276_CR30","unstructured":"Welcome to OMOP \u2013 OHDSI [Internet]. [cited 2022 Apr 12]. https:\/\/ohdsi.org\/omop\/. Accessed 10 Jan 2022."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-023-01276-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-023-01276-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-023-01276-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T16:25:33Z","timestamp":1678119933000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40264-023-01276-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,24]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["1276"],"URL":"https:\/\/doi.org\/10.1007\/s40264-023-01276-6","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,24]]},"assertion":[{"value":"23 January 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was funded by the US Food and Drug Administration (FDA) (75F40120C00123 to BAG). This publication reflects the views of the authors and should not be construed to represent FDA's views or policies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"None declared.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"This study was declared exempt from review by the DUHS IRB (protocol # Pro00104993).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Data will be made available by request to the authors.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Code will be made available upon request to the authors.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"JHH, AB, CZ, CKZ, HW, and BAG conceived and planned the analyses. AB and CZ extracted the data and conducted the analyses. JHH drafted the manuscript. JHH, HD, HPH, MP, BR, MDS, IS, MER, and JJS conducted the chart review. MDS, IS, MER, JJS, and GMD provided key clinical expertise to inform the development of the computable phenotypes. All authors provided critical feedback and helped shape the research, analysis, and manuscript. All authors read and approved the final version of the manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}